| Japanese-language VISs |
|
|
|
|
|
| You
are encouraged to distribute the current English version
at the same time as the translation. |
|
|
|
|
|
|
|
|
|
| The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current English-language version of
the following VISs. |
|
|
|
| JAPANESE TRANSLATION OF THE DECEMBER 16, 1998 CHICKENPOX VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Section 1: The answer has been rewritten by CDC. |
|
|
|
| • |
|
Section 2: There are now 2 doses; the first dose is 12-15 months and the second dose is 4-6 years. |
|
|
|
| • |
|
CDC added information on MMRV. |
|
|
|
| • |
|
The URL for Vaccine Adverse Event Reporting System (VAERS) has changed. |
|
|
|
| • |
|
The URL for the National Vaccine Injury Compensation Programs has changed. |
|
|
|
|
| JAPANESE TRANSLATION OF THE JULY 30, 2001 DTAP VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
The main change is in Section 4, which now mentions Tdap. |
|
|
|
| • |
|
The NVICP and VAERS web addresses have also been updated |
|
|
|
| • |
|
The mortality rate for tetanus in Section 1 changed from 1 out of 10, to 2 out of 10 cases. |
|
|
|
| • |
|
The date changed to 5/17/07. |
|
|
|
|
| JAPANESE TRANSLATION OF THE AUGUST 25, 1998 HEPATITIS A VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
CDC changed the indication to 1 year or older and has recommended routine use for children. |
|
|
|
| • |
|
Section 2: Added persons who work with primates or in research labs to indications (routine vaccination). |
|
|
|
| • |
|
Added bullet for "persons who live in communities that have prolonged outbreaks of hepatitis A." |
|
|
|
| • |
|
Divided the section into "Who" and "When" parts. |
|
|
|
| • |
|
Removed southern Europe from list of regions with high rates of hepatitis A. |
|
|
|
| • |
|
Section 3: Added bullet about allergy to vaccine component. |
|
|
|
| • |
|
Changed wording, particularly the statement on pregnancy, and made list into bullets. |
|
|
|
| • |
|
Minor changes to part 4, 5, and 6 to be consistent with other recent VISs. |
|
|
|
| • |
|
Removed the section on immune globulin. |
|
|
|
|
| JAPANESE TRANSLATION OF THE MAY 42, 2004 INFLUENZA TIV VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
CDC added recommending vaccination of children aged 24-59 months and their contacts. |
|
|
|
| • |
|
Section 3: CDC added to the list of people at high risk for complications from influenza, "People with certain muscle or nerve disorders (such as seizure disorders or severe cerebral palsy) that can lead to breathing or swallowing disorders." |
|
|
|
|
| JAPANESE TRANSLATION OF THE OCTOBER 2, 2005 INFLUENZA LAIV VIS |
|
|
|
| This translation does not contain the following
CDC update: |
|
| • |
|
CDC added recommending vaccination of children aged 24-59 months and their contacts. |
|
|
|
|
| JAPANESE TRANSLATION OF THE DECEMBER 16, 1998 MMR VIS |
|
|
|
| This translation does not contain the following
CDC updates: |
|
| • |
|
Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions. |
|
|
|
| • |
|
The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately. |
|
|
|
|
| JAPANESE TRANSLATION OF THE SEPTEMBER 30, 2002 PNEUMOCOCCAL VIS |
|
|
|
| This translation does not contain the following
CDC update: |
|
| • |
|
The CDC posted an updated interim PCV VIS on 12/9/08. The main reason is to incorporate recent changes in recommendations for 2-4 year olds, but there are other changes throughout as well. There are no changes in contraindications or adverse events, but to prevent parents from getting confused about the differences in indications (especially when the vaccine is administered to 2-4 year olds) it would be best for providers to start using the new version right away. Existing stocks CAN still be used temporarily if immediately switching to the new version is a problem. |
|
|
|
|
| JAPANESE TRANSLATION OF THE JUNE 10, 1994 TD VIS |
|
| *Td VIS was replaced on November 18, 2008 with the Td/Tdap VIS |
|
| For the out-of-date Td translation, visit the Td/Tdap VIS section |
|
| Thanks to the California Department of Health Services for their translations. |
|
| This page was reviewed on February 26, 2009 |
Immunization Action Coalition
IAC Home